Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr
Authors:
- 17 April 2004
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (5) , 520-523
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- CaspofunginClinical Infectious Diseases, 2003
- Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicansJournal of Antimicrobial Chemotherapy, 2003
- Successful Control of Disseminated Scedosporium prolificans Infection with a Combination of Voriconazole and TerbinafineEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- In Vitro Activities of Terbinafine in Combination with Fluconazole, Itraconazole, Voriconazole, and Posaconazole against Clinical Isolates of Candida glabrata with Decreased Susceptibility to AzolesJournal of Clinical Microbiology, 2002
- In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium sppAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activities of Terbinafine against Aspergillus Species in Comparison with Those of Itraconazole and Amphotericin BAntimicrobial Agents and Chemotherapy, 2001
- Synergism of Voriconazole and Terbinafine against Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal CandidiasisAntimicrobial Agents and Chemotherapy, 2001
- New investigational antifungal agents for treating invasive fungal infectionsExpert Opinion on Investigational Drugs, 2000
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year AnalysisClinical Infectious Diseases, 1999
- Successful Medical Therapy for Deeply Invasive Facial Infection Due to Pythium insidiosum in a ChildClinical Infectious Diseases, 1998